UY30111A1 - Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida - Google Patents

Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida

Info

Publication number
UY30111A1
UY30111A1 UY30111A UY30111A UY30111A1 UY 30111 A1 UY30111 A1 UY 30111A1 UY 30111 A UY30111 A UY 30111A UY 30111 A UY30111 A UY 30111A UY 30111 A1 UY30111 A1 UY 30111A1
Authority
UY
Uruguay
Prior art keywords
salts
carboxamide
oxo
addition salts
trifluormetil
Prior art date
Application number
UY30111A
Other languages
English (en)
Inventor
Amedeo Leonardi
Gianni Motta
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of UY30111A1 publication Critical patent/UY30111A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

La invencinn provee sales de adicinn e N-3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifuormetil-7H-tieno(3,2-b)piran-3-carboxamida con rcidos inorgrnicos, sulfnnicos o carboxelicos. Las sales preferidas son aquellas formadas con rcidos clorhedrico, bromhedrico, metansulfnnico, bencensulfnnico, toluensulfnnico o naftalen-1,5-disulfnnico. Es aun mrs prferida una sal mesilato cristalina en una forma polimnrfica unica. Las sales de la invencinn son con preferencia al menos 95% puras, conteniendo las impurezas no mrs de 2% en peso del total del subproducto N-(3-4-(2-metoxifenil)-1-piperazinil)-propil)-4-hidroxi-5-((Z)-4,4,4-trifluor-3-hidroxi-2-butenoil)-tiofen-3-carboxamida. Tambicn se proveen composiciones farmaccutias que contienen las sales de la invencinn. Las sales de la invencinn y las composiciones farmaccuticas que las contienen son utiles para el tratamiento de sendromes obstructivos del tracto urinario inferior, que incluyen HPB.
UY30111A 2006-02-03 2007-01-25 Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida UY30111A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76482406P 2006-02-03 2006-02-03

Publications (1)

Publication Number Publication Date
UY30111A1 true UY30111A1 (es) 2007-04-30

Family

ID=37983328

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30111A UY30111A1 (es) 2006-02-03 2007-01-25 Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida

Country Status (6)

Country Link
US (1) US20070185129A1 (es)
AR (1) AR059302A1 (es)
PE (1) PE20070950A1 (es)
TW (1) TW200804395A (es)
UY (1) UY30111A1 (es)
WO (1) WO2007088063A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8557807B2 (en) * 2008-01-24 2013-10-15 Signal Rx Pharmaceuticals, Inc. Thienopyranones as kinase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387909B1 (en) * 1999-07-30 2002-05-14 Recordati S.A. Chemical And Pharmaceutical Company Thienopyranecarboxamide derivatives
IT1313581B1 (it) * 1999-07-30 2002-09-09 Recordati Chem Pharm Derivati tienopirancarbossamidici.
US6306861B1 (en) * 1999-07-30 2001-10-23 Recordati S.A. Chemical And Pharmaceutical Company Thienopyrancecarboxamide derivatives
TWI265925B (en) * 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
ITMI20010164A1 (it) * 2001-01-30 2002-07-30 Recordati Chem Pharm Alfa 1 antagonisti selettivi a + d
JP2004536816A (ja) * 2001-06-05 2004-12-09 リリー アイコス リミテッド ライアビリティ カンパニー Ｐｄｅ５阻害剤としてのカルボリン誘導体

Also Published As

Publication number Publication date
US20070185129A1 (en) 2007-08-09
PE20070950A1 (es) 2007-09-10
AR059302A1 (es) 2008-03-26
TW200804395A (en) 2008-01-16
WO2007088063A1 (en) 2007-08-09

Similar Documents

Publication Publication Date Title
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
DK1856045T3 (da) 1-eddikesyreindolderviater med PGD2-antagonisteffekt
PE20060748A1 (es) Derivados de indolcarboxamida como inhibidores de quinasa ikk2
PE20080186A1 (es) Derivados 4,6-disustituidos de 2-metoxi-6-etilamino-pirimidina como antagonistas del receptor de prostaglandina d2
CY1112011T1 (el) Παραγωγα αζαδικυκλο (3.1.0) εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
CR7496A (es) Piridinoilpiperidinas como agonistas de 5- ht1f
ATE490257T1 (de) Kristalline formen von pemetrexed-disäure und herstellungsverfahren dafür
PE20050948A1 (es) Compuestos de carbamoil-amina como inhibidores de la dipeptidil peptidasa iv
NO20053794L (no) N-(1-benzyl-2-oxo-2-(1-piperazinyl) etyl)-1-piperidinkarboksamid-derivater og relaterte forbindelsers bruk som CGRP-antagonister for behandling av hodepine.
DE602007008550D1 (de) 3,7-diamino-10h-phenothiazinsalze und ihre verwendung
ECSP055615A (es) Nuevos compuestos de amida de ácido carboxílico con efecto antagónico de la hcm, medicamentos que contienen estos compuestos y procedimientos para su preparación
NO20063748L (no) Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer
NO20073957L (no) Farmasoytiske forbindelser
ATE483679T1 (de) Substituierte cyclohexylessigsäure-derivate
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
NO20091782L (no) Fremgangsmate for syntese av derivater av 3-amino-tetrahydrofuran-3-karboxylsyre og deres anvendelse som medikamenter
DE602006014022D1 (de) 5-substituierte indol-2-carbonsäureamidderivate
PE20060881A1 (es) Sulfonamido-macrociclos y sus sales como inhibidores de tie2 y composiciones farmaceuticas que comprenden estos compuestos
BRPI0517024A (pt) conjugados com atividade antiinflamatória
ATE434605T1 (de) Inhibitoren des serotonintransporters (sert)
EA201071299A1 (ru) 5-[5-[2-(3,5-бис(трифторметил)фенил)-2-метилпропаноилметиламино]-4-(4-фтор-2-метилфенил)]-2-пиридинил-2-алкилпролинамиды в качестве антагонистов рецептора nk1
ES2384517T3 (es) Procedimiento para la producción de una sal de un aducto de ácido de un compuesto alcalino poliacídico
ATE495159T1 (de) Diaminocyclohexan- und diaminocyclopentanderivate
UY30111A1 (es) Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida
UA97957C2 (ru) 2-{5-фтор-2-метил-3-[2-(фенилсульфонил)бензил]-1н-индол-1-ил}уксусная кислота и ее производные, их применение для лечения заболеваний, опосредствованных действием pgd2 на рецептор crth2